+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) S1 Protein RBD (Alpha B.1.1.7 Variant) |
Target Modification | Asn501Tyr |
Modification | Mutation |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB |
Host | Insect |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Liquid |
Purity | ≥ 90% (SDS-PAGE) |
Purification | Purified by affinity chromatography. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Molecular Weight | Calculated MW: 26 kDa Observed MW (12% reducing SDS-PAGE): ~28 kDa |
Sequence Fragment | 319-541 AA. |
Tag | C-terminal His tag |
Buffer | PBS, pH 7.4. Does not contain preservatives. |
Concentration | 2.2 mg/ml |
Availability | Shipped within 10-20 working days. |
Note | This product is for research use only. This product is shipped with dry ice. |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |